A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This clinical study aims to evaluate the safety and tolerability of intra-arterial Yttrium-90 (90Y) glass microspheres in patients with unresectable pancreatic adenocarcinoma. The study will assess radiation dose distribution, adverse effects, and preliminary efficacy following selective arterial radioembolization.
Epistemonikos ID: c47b6c4e44580468f28a2bbd2a3166b1323c6342
First added on: Oct 28, 2026